A Multi-Center Phase II Study of Selinexor in Treating Recurrent or Refractory Wilms Tumor and Other Pediatric Solid Tumors
Latest Information Update: 03 May 2025
At a glance
- Drugs Selinexor (Primary)
- Indications Neurofibrosarcoma; Rhabdoid tumour; Solid tumours; Wilms' tumour
- Focus Therapeutic Use
Most Recent Events
- 17 Aug 2023 New trial record